Tuesday, February 8, 2011

News updates

Here are some updates of shares I have been following.

AZN.L AstraZeneca's run of disappointing drug development results has continued with the early end to a trial of prostate cancer treatment zibotentan.

BWY.L Housebuilder Bellway has been encouraged by the pick up in site visits and reservations in 2011 following the cold snap in December. The group said it sold 2,332 homes in the six months to end-January, an increase of 85 on the corresponding period a year earlier. The average sales price over the period rose to £168,000 from £155,871 a year earlier, largely as a result of selling more traditional two storey homes and fewer flats.

No comments: